188 related articles for article (PubMed ID: 22365088)
1. Nonclassical biological activities of quinolone derivatives.
Ahmed A; Daneshtalab M
J Pharm Pharm Sci; 2012; 15(1):52-72. PubMed ID: 22365088
[TBL] [Abstract][Full Text] [Related]
2. The quinolone family: from antibacterial to anticancer agents.
Sissi C; Palumbo M
Curr Med Chem Anticancer Agents; 2003 Nov; 3(6):439-50. PubMed ID: 14529452
[TBL] [Abstract][Full Text] [Related]
3. The 4-quinolone-3-carboxylic acid motif as a multivalent scaffold in medicinal chemistry.
Mugnaini C; Pasquini S; Corelli F
Curr Med Chem; 2009; 16(14):1746-67. PubMed ID: 19442143
[TBL] [Abstract][Full Text] [Related]
4. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
5. Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde.
Anderson VE; Osheroff N
Curr Pharm Des; 2001 Mar; 7(5):337-53. PubMed ID: 11254893
[TBL] [Abstract][Full Text] [Related]
6. Functionalized N(2-oxyiminoethyl) piperazinyl quinolones as new cytotoxic agents.
Rajabalian S; Foroumadi A; Shafiee A; Emami S
J Pharm Pharm Sci; 2007; 10(2):153-8. PubMed ID: 17706174
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumour activities of quinolone antineoplastic agents.
Chu DT; Hallas R; Clement JJ; Alder J; McDonald E; Plattner JJ
Drugs Exp Clin Res; 1992; 18(7):275-82. PubMed ID: 1338309
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of modified quinolones as antitumoral acridones.
Tabarrini O; Cecchetti V; Fravolini A; Nocentini G; Barzi A; Sabatini S; Miao H; Sissi C
J Med Chem; 1999 Jun; 42(12):2136-44. PubMed ID: 10377219
[TBL] [Abstract][Full Text] [Related]
9. Antiviral properties of quinolone-based drugs.
Richter S; Parolin C; Palumbo M; Palù G
Curr Drug Targets Infect Disord; 2004 Jun; 4(2):111-6. PubMed ID: 15180459
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the synthetic and medicinal perspective of quinolones: A review.
Dhiman P; Arora N; Thanikachalam PV; Monga V
Bioorg Chem; 2019 Nov; 92():103291. PubMed ID: 31561107
[TBL] [Abstract][Full Text] [Related]
11. Perspectives on the development of novel potentially active quinolones against tuberculosis and cancer.
Facchinetti V; Gomes CR; de Souza MV; Vasconcelos TR
Mini Rev Med Chem; 2012 Aug; 12(9):866-74. PubMed ID: 22512569
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
Vandurm P; Guiguen A; Cauvin C; Georges B; Le Van K; Michaux C; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
Eur J Med Chem; 2011 May; 46(5):1749-56. PubMed ID: 21385662
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the discovery and development of quinolones and analogs as antitumor agents.
Xia Y; Yang ZY; Morris-Natschke SL; Lee KH
Curr Med Chem; 1999 Mar; 6(3):179-94. PubMed ID: 10219099
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumour activities of tetracyclic quinolone antineoplastic agents.
Chu DT; Hallas R; Tanaka SK; Alder J; Balli D; Plattner JJ
Drugs Exp Clin Res; 1994; 20(5):177-83. PubMed ID: 7875053
[TBL] [Abstract][Full Text] [Related]
15. Recent insight into the biological activities and SAR of quinolone derivatives as multifunctional scaffold.
Sharma V; Das R; Kumar Mehta D; Gupta S; Venugopala KN; Mailavaram R; Nair AB; Shakya AK; Kishore Deb P
Bioorg Med Chem; 2022 Apr; 59():116674. PubMed ID: 35202969
[TBL] [Abstract][Full Text] [Related]
16. Antitumor quinolones with mammalian topoisomerase II mediated DNA cleavage activity.
Yamashita Y; Ashizawa T; Morimoto M; Hosomi J; Nakano H
Cancer Res; 1992 May; 52(10):2818-22. PubMed ID: 1316228
[TBL] [Abstract][Full Text] [Related]
17. Recent developments of quinolone-based derivatives and their activities against Escherichia coli.
Gao F; Wang P; Yang H; Miao Q; Ma L; Lu G
Eur J Med Chem; 2018 Sep; 157():1223-1248. PubMed ID: 30193220
[TBL] [Abstract][Full Text] [Related]
18. A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone.
Bisacchi GS; Hale MR
Curr Med Chem; 2016; 23(6):520-77. PubMed ID: 26695512
[TBL] [Abstract][Full Text] [Related]
19. Quinoline and quinolone dimers and their biological activities: An overview.
Chu XM; Wang C; Liu W; Liang LL; Gong KK; Zhao CY; Sun KL
Eur J Med Chem; 2019 Jan; 161():101-117. PubMed ID: 30343191
[TBL] [Abstract][Full Text] [Related]
20. Quinolines and Quinolones as Antibacterial, Antifungal, Anti-virulence, Antiviral and Anti-parasitic Agents.
Senerovic L; Opsenica D; Moric I; Aleksic I; Spasić M; Vasiljevic B
Adv Exp Med Biol; 2020; 1282():37-69. PubMed ID: 31515709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
